| abstract |
The present disclosure relates to systems and methods for assessing viral, e.g. , HIV, infection duration in a subject. More specifically, the present disclosure relates to for assessing viral, e.g. , HIV, infection duration in a subject using, inter alia, a reader configured to measure both the number of signal pixels and the intensities of signal pixels to generate a quantitative signal readout that is used to assess average antibody avidity of an anti- viral antibody, e.g. , an anti-HIV antibody, in a sample liquid and/or viral, e.g. , HIV, infection duration in a subject. |